What You Should Know:
– Caris Life Sciences® (Caris), an AI TechBio company and pioneer in precision medicine, today announced the pricing of its initial public offering (IPO) of 23,529,412 shares of its common stock at a public offering price of $21.00 per share.
– The shares are expected to begin trading on the Nasdaq Global Select Market on June 18, 2025, under the ticker symbol “CAI.” The offering is expected to close on June 20, 2025, subject to customary closing conditions.
Offering Details
In addition to the shares being offered, Caris has granted the underwriters a 30-day option to purchase up to an additional 3,529,411 shares of common stock at the initial public offering price, less underwriting discounts and commissions.
